Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Feb 6:14:1112860.
doi: 10.3389/fphys.2023.1112860. eCollection 2023.

Editorial: Ozone in medicine: Biochemical background, physiological modulation and clinical applications

Affiliations
Editorial

Editorial: Ozone in medicine: Biochemical background, physiological modulation and clinical applications

Bernardino Clavo et al. Front Physiol. .
No abstract available

Keywords: Nrf2; bronchial asthma; chemotherapy-induced peripheral neuropathy (CIPN); oxidative stress; ozone therapy; pain; rheumathoid arthritis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Adaptive response of the organism to psychological, physical or oxidative “stress level”.

Comment on

  • Editorial on the Research Topic Ozone in medicine: Biochemical background, physiological modulation and clinical applications

Similar articles

Cited by

References

    1. Bocci V. A., Zanardi I., Travagli V. (2011). Ozone acting on human blood yields a hormetic dose-response relationship. J. Transl. Med. 9, 66. 10.1186/1479-5876-9-66 - DOI - PMC - PubMed
    1. Bocci V., Borrelli E., Travagli V., Zanardi I. (2009). The ozone paradox: Ozone is a strong oxidant as well as a medical drug. Med. Res. Rev. 29 (4), 646–682. 10.1002/med.20150 - DOI - PubMed
    1. Bocci V. (2011). Ozone. A new medical drug. Berlin, Germany: Springer-Verlag, 315.
    1. Borrelli E. (2021). The problem of chronic oxidative stress and the systemic indirect ozone therapy as a possible solution. Highlight Med. Med. Res. 4, 135–140. 10.9734/bpi/hmmr/v4/1739F - DOI
    1. Calabrese E. J., Kozumbo W. J. (2021). The hormetic dose-response mechanism: Nrf2 activation. Pharmacol. Res. 167, 105526. 10.1016/j.phrs.2021.105526 - DOI - PubMed

Publication types

LinkOut - more resources